Document ID: chunk:federal_register_of_legislation:F2023L00011:reg:9:p4
Version: federal_register_of_legislation:F2023L00011
Segment Type: reg
Provision Reference: reg 9 (pt 4/7)
Character Range: 13487–16498

30 days of cessation of therapy;
Note: glucocorticoid therapy as specified is defined in the Schedule 1 - Dictionary.
(37)      taking a drug from the specified list of drugs within the 7 days before the clinical onset of atrial fibrillation or atrial flutter;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(38)      having valvular heart disease at the time of the clinical worsening  of atrial fibrillation or atrial flutter;
Note 1: valvular heart disease is defined in the schedule 1 Dictionary.
(39)      having ischaemic heart disease at the time of the clinical worsening of atrial fibrillation or atrial flutter;
(40)      having non-infectious myocarditis at the time of the clinical  worsening of atrial fibrillation or atrial flutter;
Note 1: Non-infectious myocarditis can be acute or chronic.
Note 2: Non-infectious myocarditis can be of autoimmune, infiltrative or immunological origin. Examples of causes of non-infectious myocarditis include immune checkpoint inhibitor therapy and giant cell myocarditis.
(41)      having viral myocarditis at the time of the clinical worsening of atrial fibrillation or atrial flutter;
Note 1: Viral myocarditis can be acute or chronic.
Note 2: Examples of viral causes of myocarditis include severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and dengue virus.
(42)      having a non-viral infection of the myocardium at the time of the clinical worsening of atrial fibrillation or atrial flutter;
Note: Examples of causes of non-viral infection of the myocardium include Borrelia burgdorferi and leptospirosis.
(43)      having pericarditis at the time of the clinical worsening of atrial fibrillation or atrial flutter;
(44)      having cardiomyopathy at the time of the clinical worsening of atrial fibrillation or atrial flutter;
(45)      having heart failure at the time of the clinical worsening of atrial fibrillation or atrial flutter;
(46)      having hypertension before the clinical worsening  of atrial fibrillation or atrial flutter;
(47)      having pulmonary thromboembolism within the 30 days before the clinical worsening of atrial fibrillation or atrial flutter;
(48)      having a thyroid condition from the specified list of thyroid conditions at the time of the clinical worsening of atrial fibrillation or atrial flutter;
Note: specified list of thyroid conditions is defined in the Schedule 1 – Dictionary.
(49)      consuming an average of at least 150 grams of alcohol per week for a continuous period of at least the 5 years before the clinical worsening of atrial fibrillation or atrial flutter;
Note: Alcohol consumption is calculated utilising the Australian Standard of 10 grams of alcohol per standard alcoholic drink.
(50)      binge drinking within the 2 days before the clinical worsening of atrial fibrillation or atrial flutter;
Note: binge drinking is defined in the Schedule 1 – Dictionary.
(51)      having a thoracic surgical procedure or an invasive cardiac procedure within the 1